Framingham Heart Study, Framingham, Massachusetts, United States of America.
Department of Medicine, Cardiology Section, Boston VA Healthcare System, West Roxbury, Massachusetts, United States of America.
PLoS One. 2020 Apr 10;15(4):e0231254. doi: 10.1371/journal.pone.0231254. eCollection 2020.
Heart failure (HF) is a clinical syndrome where diagnostic certainty varies. The prognosis of individuals with some clinical features of HF, but without the fully overt syndrome, is unclear. Therefore, we sought to evaluate their natural history.
Between 1990 and 2009, all suspected HF cases in the Framingham Heart Study were adjudicated into 3 groups reflecting varying diagnostic certainty: definite (meeting HF diagnostic criteria; n = 479), possible (meeting HF criteria but with an alternative explanation for findings; n = 135), and probable (insufficient criteria for definite HF; n = 121) HF. Age-and-sex-matched individuals (n = 1112) without HF or cardiovascular disease (CVD) were controls. Using multivariable-adjusted Cox regression, we compared the possible/probable HF groups with controls regarding risk of incident definite HF, coronary heart disease (CHD), other CVD or death; and with definite HF regarding risk of latter three outcomes. During follow-up (mean 8.6 years), ~90% of individuals with possible, probable and definite HF experienced CVD events or died. Compared with controls, those with possible or probable HF experienced higher hazards for definite HF, CHD, other CVD and death (hazards ratios [HR] 1.35-9.31; p<0.05). The possible/probable groups did not differ from the definite HF group for risk of any outcome. Compared with the possible HF group, the probable HF group had a higher propensity for definite HF (HR 1.64, with a higher proportion of ischemic HF) but lower risk of death (HR 0.69).
Individuals meeting partial criteria for HF are at a substantial risk for progression to HF, CVD, and mortality.
心力衰竭(HF)是一种临床综合征,其诊断的确定性存在差异。对于某些具有 HF 临床特征但尚未出现完全显性综合征的个体,其预后尚不清楚。因此,我们试图评估他们的自然病程。
在 1990 年至 2009 年间,弗雷明汉心脏研究中的所有疑似 HF 病例均被判定为 3 组,以反映不同的诊断确定性:明确(符合 HF 诊断标准;n=479)、可能(符合 HF 标准但对检查结果有其他解释;n=135)和可能(不完全符合明确 HF 的标准;n=121)HF。年龄和性别匹配(n=1112)无 HF 或心血管疾病(CVD)的个体为对照组。采用多变量调整的 Cox 回归,我们比较了可能/可能 HF 组与对照组在发生明确 HF、冠心病(CHD)、其他 CVD 或死亡的风险方面;以及与明确 HF 组在后三种结局的风险方面。在随访期间(平均 8.6 年),约 90%的可能、可能和明确 HF 患者经历了 CVD 事件或死亡。与对照组相比,可能或可能 HF 患者发生明确 HF、CHD、其他 CVD 和死亡的风险更高(风险比 [HR] 1.35-9.31;p<0.05)。可能/可能 HF 组与明确 HF 组在任何结局的风险上没有差异。与可能 HF 组相比,可能 HF 组发生明确 HF 的可能性更高(HR 1.64,且缺血性 HF 的比例更高),但死亡风险较低(HR 0.69)。
符合 HF 部分标准的个体发生 HF、CVD 和死亡的风险很大。